SBRT

20 registered clinical trials studyying SBRT — 8 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Benmelstobart Plus Anlotinib Combined With SBRT for Patients With Hepatocellular Carcinoma Failing First-Line NCT07537777	Nanfang Hospital, Southern Medical University	Phase 2
Recruiting	Single-Fraction Pulmonary Ablative Radiotherapy Outcomes and Quality-of-life Workup NCT07441941	Institut du Cancer de Montpellier - Val d'Aurelle	—
Active Not Recruiting	SENECA: First Line metaStatic pancrEatic caNcer Primary and Distant (if Oligometastatic) lEsion direCted rAdio NCT06946420	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	Phase 3
Not Yet Recruiting	SBRT Combined With Adbelimumab and Apatinib for Perioperative and Conversion Therapy of Hepatocellular Carcino NCT06538935	Fujian Cancer Hospital	Phase 2
Not Yet Recruiting	Efficacy and Safety of a Third-Course of Neoadjuvant Immunochemotherapy Combined With SBRT in Locally Advanced NCT06722495	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	N/A
Recruiting	SBRT Combined With Nimotuzumab and Tislelizumab for Oligoprogressive Recurrent/Metastatic Nasopharyngeal Carci NCT06676722	The First Affiliated Hospital of Xiamen University	Phase 2
Enrolling By Invitation	A Phase I Dose-escalation Trial of Definitive Single Dose Stereotactic Body Radiotherapy in Low-risk Breast Ca NCT06671691	Universitat de les Illes Balears	Phase 1
Active Not Recruiting	Sequential TACE-SBRT Combined With Targeted Immunotherapy for Patients With Intermediate to Advanced Liver Can NCT07230080	Nanfang Hospital, Southern Medical University	—
Recruiting	SBRT Followed by Neoadjuvant Chemoimmunotherapy of Sindilizumab Plus Docetaxel and Cisplatin for Locoregionall NCT06219980	Sun Yat-sen University	Phase 2
Active Not Recruiting	Stereotactic Body Radiotherapy (SBRT) for Medically Inoperable Localised Renal Tumors (SABINA Trial) NCT05817604	Consorci Sanitari de Terrassa	—
Recruiting	Observational Study on Extreme Hypofractionation for Localized Prostate Cancer NCT05344235	Universitaire Ziekenhuizen KU Leuven	—
Unknown	Lung Perfusion PET / CT Using Ga68-MAA for Preservation of Lung Function During Stereotactic Pulmonary Radiati NCT04942275	University Hospital, Brest	Phase 2 / Phase 3
Terminated	Phase 2b Study of GC4711 in Combination With SBRT for Nonmetastatic Pancreatic Cancer NCT04698915	Galera Therapeutics, Inc.	Phase 2
Terminated	Phase I/II Study of SBRT and GC4711 for Centrally Located or Large NSCLC NCT04476797	Galera Therapeutics, Inc.	Phase 1 / Phase 2
Unknown	Combination of Hyperfractionated Radiotherapy With Immunotherapy in Massive Tumors NCT04587817	Peking University First Hospital	—
Unknown	Combination of Sintilimab and Stereotactic Body Radiotherapy in Advanced Metastatic HCC NCT04547452	West China Hospital	Phase 2
Active Not Recruiting	Post-Prostatectomy Linac-Based Ultrahypofractionated Radiotherapy for Patients With Localized Prostate Cancer NCT04067570	Sunnybrook Health Sciences Centre	N/A
Completed	Clinical Phase II Clinical Study Evaluating the Toxicity and Efficacy of mFOLFIRINOX Associated With SBRT (Ste NCT03891472	Medical University of Silesia	Phase 2
Unknown	Stereotactic Hypofractionated Accelerated Radiotherapy Post-Prostatectomy NCT02976402	Fundacao Champalimaud	Phase 1
Unknown	SBRT in Multi-metastatic NSCLC Patients Which Are Pan-negative for Driver Mutations NCT02940990	Shanghai Chest Hospital	Phase 2